PUBLIC COMPANY
saveRecode Therapeutics Inc
updated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
- phase1Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance
- phase1A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD
- —A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
- —A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
- phase1Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects
🐶 Hiring Signal
News
- No ‘Sunday scaries’: Claire Mazumdar on building Bicara—and knowing when to hand over the reinsStrange and bittersweet. That’s how Claire Mazumdar describes her plan to step down from the top spot at Bicara, a biotech she helped form, and head out on parental leave before transitioning into…biospace · 3d ago
- ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s handsAfter achieving clinical validation earlier this year, ReCode Therapeutics has called up a new CEO to take on the mission of advancing programs for cystic fibrosis and primary ciliary dyskinesia th…biospace · 10d ago
- Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challengeA group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the abortion pill mifep…fiercebiotech · 2mo ago
comments(0)
5-min edit window · permanent after that